|
|
Prepublished online as a Blood First Edition Paper on February 27, 2003; DOI 10.1182/blood-2002-11-3483.
 Previous Article | Table of Contents | Next Article 
Blood, 15 June 2003, Vol. 101, No. 12, pp. 4836-4843
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow
Patricia Lagadec,
Olivier Dejoux,
Michel Ticchioni,
Françoise Cottrez,
Mette Johansen,
Eric J. Brown, and
Alain Bernard
From the Unité Institut National de la Santé et de la Recherche Médicale (INSERM) U343 et Laboratoire d'Immunologie, Nice, France; and the University of California at San Francisco.
Resting platelet adhesion to inflammatory vascular endothelium is thought to play a causal role in secondary thrombus formation or microcirculatory disturbance after vessel occlusion. However, though adhesion receptors involved in platelet-matrix interactions have been extensively studied, the molecular mechanisms involved in platelet-endothelium interactions are incompletely characterized and have been mainly studied under static conditions. Using human platelets or platelets from wild-type and CD47–/– mice in whole blood, we demonstrated that at low shear rate, CD47 expressed on human and mouse platelets significantly contributes to platelet adhesion on tumor necrosis factor- (TNF-)–stimulated vascular endothelial cells. Using the CD47 agonist peptide 4N1K and blocking monoclonal antibodies (mAbs), we showed that CD47 binds the cell-binding domain (CBD) of endothelial thrombospondin-1 (TSP-1), inducing activation of the platelet IIb 3 integrin that in turn becomes able to link the endothelial receptors intercellular adhesion molecule 1 (ICAM-1) and v3. Platelet CD36 and GPIb are also involved because platelet incubation with blocking mAbs directed against each of these 2 receptors significantly decreased platelet arrest. Given that anti-CD47 treatment of platelets did not further decrease the adhesion of anti-CD36–treated platelets and CD36 is a TSP-1 receptor, it appears that CD36/TSP-1 interaction could trigger the CD47-dependent pathway. Overall, CD47 antagonists may be potentially useful to inhibit platelet adhesion on inflamed endothelium.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Bonnefoy, K. Daenens, H. B. Feys, R. De Vos, P. Vandervoort, J. Vermylen, J. Lawler, and M. F. Hoylaerts
Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13
Blood,
February 1, 2006;
107(3):
955 - 964.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Tull, S. I. Anderson, S. C. Hughan, S. P. Watson, G. B. Nash, and G. E. Rainger
Cellular Pathology of Atherosclerosis: Smooth Muscle Cells Promote Adhesion of Platelets to Cocultured Endothelial Cells
Circ. Res.,
January 6, 2006;
98(1):
98 - 104.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Rosenthal-Allieri, M. Ticchioni, J. P. Breittmayer, Y. Shimizu, and A. Bernard
Influence of {beta}1 Integrin Intracytoplasmic Domains in the Regulation of VLA-4-Mediated Adhesion of Human T Cells to VCAM-1 under Flow Conditions
J. Immunol.,
July 15, 2005;
175(2):
1214 - 1223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tabibiazar, R. A. Wagner, J. M. Spin, E. A. Ashley, B. Narasimhan, E. M. Rubin, B. Efron, P. S. Tsao, R. Tibshirani, and T. Quertermous
Mouse Strain-Specific Differences in Vascular Wall Gene Expression and Their Relationship to Vascular Disease
Arterioscler Thromb Vasc Biol,
February 1, 2005;
25(2):
302 - 308.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Shattil and P. J. Newman
Integrins: dynamic scaffolds for adhesion and signaling in platelets
Blood,
September 15, 2004;
104(6):
1606 - 1615.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
